Immune System Stimulation by Oncolytic Rodent Protoparvoviruses
AbstractRodent protoparvoviruses (PVs), parvovirus H-1 (H-1PV) in particular, are naturally endowed with oncolytic properties. While being historically described as agents that selectively replicate in and kill cancer cells, recent yet growing evidence demonstrates that these viruses are able to reverse tumor-driven immune suppression through induction of immunogenic tumor cell death, and the establishment of antitumorigenic, proinflammatory milieu within the tumor microenvironment. This review summarizes the most important preclinical proofs of the interplay and the cooperation between PVs and the host immune system. The molecular mechanisms of PV-induced immunostimulation are also discussed. Furthermore, initial encouraging in-human observations from clinical trials and compassionate virus uses are presented, and speak in favor of further H-1PV clinical development as partner drug in combined immunotherapeutic protocols. View Full-Text
Share & Cite This Article
Angelova, A.; Rommelaere, J. Immune System Stimulation by Oncolytic Rodent Protoparvoviruses. Viruses 2019, 11, 415.
Angelova A, Rommelaere J. Immune System Stimulation by Oncolytic Rodent Protoparvoviruses. Viruses. 2019; 11(5):415.Chicago/Turabian Style
Angelova, Assia; Rommelaere, Jean. 2019. "Immune System Stimulation by Oncolytic Rodent Protoparvoviruses." Viruses 11, no. 5: 415.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.